News

Myeloma Trial Results Spark Talk of 'Potential Cure' — One-third of patients alive and progression-free 5 or more years after a single infusion ...
Roche is to buy gene therapy firm Spark Therapeutics for $4.8 billion, adding an already-approved treatment for inherited blindness to its portfolio, and boosting its pipeline with a series of ...
Spark New Zealand Limited (SPK), an ASX-listed company, operates as a telecommunications service provider in New Zealand, catering to both consumer and business segments. The company is organized into ...